Television station WWOR solicited addiction expert, Dr. Cidambi’s opinion on Probuphine, an implantable form of buprenorphine, recently approved by the FDA. Probuphine is recommended for maintenance treatment of dependence on opiates. It is to be used to address opiate cravings and opiate withdrawal.